Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

Atopiclair - innovative non-steroidal cream for atopic dermatitis

Sinclair Pharmaceuticals
New cream formulation to manage the symptoms of atopic dermatitis.

Mechanism of action

Multi-functional

Full description

Atopiclair is a new non-steroidal cream, which has been especially formulated to manage the symptoms of atopic dermatitis. It acts by adhering to the injured tissue and protecting it from further irritation and also maintains a moist wound and skin environment, which is beneficial to the healing process. Efficacy in relieving the symptoms of atopic dermatitis, has been demostrated in controlled studies.

 

 

Development status

Registered

Patent information

Patents pending.

Type of business relationship sought

Exclusive agreements on a territory and/or regional basis for the marketing and distribution of finished product.

Partnering consultation free of charge
EuroPLX 38 + 39
Need competitive intelligence information
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us